Open Angle Glaucoma Treatment Preferences of Glaucoma Specialists in the United States.
Liu Jocelyn, Kim Iris M, Chen Evan M, Porco Travis C, McLeod Stephen D, Gazzard Gus, O'Brien Kieran S, Sun Catherine Q
AI Summary
US glaucoma specialists increasingly prefer SLT over topical medications for treatment-naive open-angle glaucoma, indicating a shift towards SLT as a primary therapy.
Abstract
Précis: This cross-sectional survey study evaluated the current treatment preferences of US glaucoma specialists for open angle glaucoma, finding that most preferred selective laser trabeculoplasty over topical medications for treatment-naive patients with ocular hypertension and open angle glaucoma.
Purpose
To describe US glaucoma specialists' preferences regarding the use of selective laser trabeculoplasty (SLT) versus topical glaucoma medications for the treatment of open angle glaucoma.
Methods
Actively practicing glaucoma specialists from the American Glaucoma Society were invited to participate in a survey assessing treatment preferences and influencing factors. Multivariable logistic regressions were performed to determine predictors of preference for SLT.
Results
Of 136 eligible respondents, 65%-71% preferred SLT for treatment-naive patients with ocular hypertension, mild-to-moderate primary open angle glaucoma (POAG), pseudoexfoliation glaucoma, or pigmentary glaucoma. For mild-to-moderate POAG on one medication, 75% of respondents favored SLT. For advanced POAG on maximum medical therapy, 57% of respondents favored surgery and 38% preferred SLT. Respondents indicated that reducing medication nonadherence (93%), suitable glaucoma type or stage (88%), and experience performing SLT (83%) were key facilitators in recommending SLT to their patients. In contrast, patients' inability to position for the procedure (78%), unsuitable glaucoma type or stage (67%), and comorbidities or contraindications to SLT (55%) were primary reasons to not recommend SLT. Physicians in private practice, those who completed fellowship training more recently, and those who see more treatment-naive glaucoma patients were significantly more likely to prefer SLT over medication.
Conclusion
The majority of US glaucoma specialists report a preference for SLT over medication for open angle glaucoma treatment, demonstrating that acceptance of SLT has increased over the past several years, especially for treatment-naïve patients. Statistically significant predictors of SLT preference were practice setting, practice duration, and patient volume.
MeSH Terms
Shields Classification
Key Concepts6
Most US glaucoma specialists (65%-71%) preferred selective laser trabeculoplasty (SLT) over topical medications for treatment-naive patients with ocular hypertension, mild-to-moderate primary open angle glaucoma (POAG), pseudoexfoliation glaucoma, or pigmentary glaucoma.
For mild-to-moderate primary open angle glaucoma (POAG) on one medication, 75% of US glaucoma specialists surveyed favored selective laser trabeculoplasty (SLT).
For advanced primary open angle glaucoma (POAG) on maximum medical therapy, 57% of US glaucoma specialists surveyed favored surgery and 38% preferred selective laser trabeculoplasty (SLT).
US glaucoma specialists in private practice, those who completed fellowship training more recently, and those who see more treatment-naive glaucoma patients were significantly more likely to prefer selective laser trabeculoplasty (SLT) over medication.
Key facilitators for US glaucoma specialists recommending selective laser trabeculoplasty (SLT) to their patients included reducing medication nonadherence (93%), suitable glaucoma type or stage (88%), and experience performing SLT (83%).
Primary reasons for US glaucoma specialists not to recommend selective laser trabeculoplasty (SLT) included patients' inability to position for the procedure (78%), unsuitable glaucoma type or stage (67%), and comorbidities or contraindications to SLT (55%).
Related Articles5
Laser in Glaucoma and Ocular Hypertension Trial (LIGHT) in China - A Randomized Controlled Trial: Design and Baseline Characteristics.
Randomized Controlled TrialThe laser step in early glaucoma therapy.
ReviewPractice implications of the Glaucoma Laser Trial.
Clinical TrialCurrent uses of ophthalmic lasers.
ReviewDisc hemorrhages and treatment in the early manifest glaucoma trial.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.